Link Immunotherapeutics Analysis: $51M Raised
What is Link Immunotherapeutics?
Groundbreaking therapies through rigorous science
Location
Seattle, United States
Employees
1-10
Founded
2020
Product Features & Capabilities
- Therapeutics targeting validated cancer markers
- Novel target combinations for improved efficacy
Use Cases
Develop therapies for specific cancer targets; Collaborate with industry-leading partners for research; Utilize existing knowledge to create better therapeutic molecules
Other Considerations
Founded in 2020; Based in Seattle, Washington; Supported by an experienced Board of Directors
See something that needs updating? Suggest edits to this profile.